Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.
OBJECTIVES:Management of bloodstream infections ("BSIs") caused by Pseudomonas aeruginosa remains controversial as data supporting the use of definite combination treatment for severe P. aeruginosa infections remain conflicting. We aimed to determine differences in mortality between patien...
Main Authors: | Sarah Tschudin-Sutter, Nicole Fosse, Reno Frei, Andreas F Widmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6147480?pdf=render |
Similar Items
-
The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
by: Jan A Roth, et al.
Published: (2017-01-01) -
Pseudomonas aeruginosa bloodstream infection at a tertiary referral hospital for children
by: Joycelyn Assimeng Dame, et al.
Published: (2020-10-01) -
Multidrug-Resistant Pseudomonas Aeruginosa Bloodstream Infections: Analysis of Trends in Prevalence and Epidemiology
by: Evelina Tacconelli, et al.
Published: (2002-02-01) -
<it>Actinobaculum schaalii </it>- invasive pathogen or innocent bystander? A retrospective observational study
by: Tschudin-Sutter Sarah, et al.
Published: (2011-10-01) -
Extended Spectrum β-Lactamase–producing Escherichia coli in Neonatal Care Unit
by: Sarah Tschudin-Sutter, et al.
Published: (2010-11-01)